Abstract:The use of imaging to detect and monitor the movement and accumulation of cells in living subjects can provide significant insights that can improve our understanding of metastasis and guide therapeutic development. For cell tracking using Magnetic Resonance Imaging (MRI), cells are labeled with iron oxides and the effects of the iron on water provides contrast. However, due to low specificity and difficulties in quantification with MRI, other modalities and approaches need to be developed. Magnetic Particle Imaging (MPI) is an emerging imaging technique which directly detects iron, allowing for a specific, quantitative and sensitive readout. Here, we use MPI to image iron-labeled tumor cells longitudinally, from implantation and growth at a primary site to movement to distant anatomic sites. In vivo bioluminescent imaging (BLI) was used to localize tumor metastases and computed tomography (CT) allowed for correlation of these signals to anatomic locations. These three imaging modalities provide information on immune escape and metastasis of iron-labeled, and unlabeled, tumor cells, and the accumulation of cell-free iron contrast over time. We localized iron signals by MPI and tumor cells via BLI, and correlated these positive contrast images with CT scans to reveal the anatomic sites with cancer cells; histologic analysis confirmed the presence of iron-labeled tumor cells in the tissues, suggesting that the metastatic cells retained enough iron for MPI detection. The use of multi-modality cell tracking reveals the movement, accumulation and fates of labeled cells that will be helpful understanding cancer progression and guiding the development of targeted therapies.

Dual Contrast Magnetic Resonance Imaging Tracking of Iron-Labeled Cells in Vivo

Research Progress of Magnetic Resonance Imaging Contrast Agents

Positive Contrast Imaging of SPIO Nanoparticles

Superparamagnetic Iron Oxide Nanoparticles As MRI Contrast Agents for Non-invasive Stem Cell Labeling and Tracking

Cellular magnetic resonance imaging: current status and future prospects

Magnetic Labeling and Tracking of Cells Using Magnetodendrimers As MR Contrast Agent

Comparison of Superparamagnetic and Ultrasmall Superparamagnetic Iron Oxide Cell Labeling for Tracking Green Fluorescent Protein Gene Marker with Negative and Positive Contrast Magnetic Resonance Imaging

A primer on in vivo cell tracking using MRI

Recent development in targeted MRI negative contrast based on ultra-small superparamagnetic iron oxide particles

Self-assembled Dual-Modality Contrast Agents for Non-Invasive Stem Cell Tracking Via Near-Infrared Fluorescence and Magnetic Resonance Imaging.

MRI Tracking of Dendritic Cells Loaded with Superparamagnetic Iron Oxide Nanoparticles.

In Vivo Cellular Magnetic Imaging: Labeled versus Unlabeled Cells (Adv. Funct. Mater. 50/2022)

The Application of Super Paramagnetic Iron Oxide-Labeled Mesenchymal Stem Cells in Cell-Based Therapy

Recent Advances Of Bioresponsive Nano-Sized Contrast Agents For Ultra-High-Field Magnetic Resonance Imaging

Research progress in bio-responsive MRI contrast agent

Advances in magnetic nanoparticle-based magnetic resonance imaging contrast agents

Progress of cell labeling methods using superparamagnetic iron oxides

Tracking the fates of iron-labeled tumor cells in vivo using Magnetic Particle Imaging

Recent Advances In Superparamagnetic Iron Oxide Nanoparticles For Cellular Imaging And Targeted Therapy Research

Compatibility of Superparamagnetic Iron Oxide Nanoparticle Labeling for 1H MRI Cell Tracking with 31P MRS for Bioenergetic Measurements

Paramagnetic Nanoemulsions with Unified Signals for Sensitive 19F MRI Cell Tracking